Similar articles

• Tissue Typing of cultured human tumor cell lines: the detection of genetically appropriate HLA-A, B, C, and DR alloantigens.

  Pollack MS, Heagney S, Fogh J. Pollack MS, et al. Transplant Proc. 1980 Mar;12(1):134-7. Transplant Proc. 1980. PMID: 7368285 No abstract available.
• HLA antigens in malignant melanoma.

  Bergholtz B, Brennhovd I, Klepp O, Kaakinen A, Thorsby E. Bergholtz B, et al. Prog Clin Biol Res. 1977;16:175-80. Prog Clin Biol Res. 1977. PMID: 905323
• HLA-G expression in malignant melanoma.

  Rebmann V, Wagner S, Grosse-Wilde H. Rebmann V, et al. Semin Cancer Biol. 2007 Dec;17(6):422-9. doi: 10.1016/j.semcancer.2007.06.010. Epub 2007 Jun 28. Semin Cancer Biol. 2007. PMID: 17689098 Review.
• Serologically defined B-lymphocyte antigen expression in patients with malignant melanoma.

  Nathanson SD, Park MS, Drew I, Morton DL, Terasaki PI. Nathanson SD, et al. Surg Forum. 1979;30:147-9. Surg Forum. 1979. PMID: 317176 No abstract available.
• HLA-G expression: immune privilege for tumour cells?

  Cabestre FA, Lefebvre S, Moreau P, Rouas-Friess N, Dausset J, Carosella ED, Paul P. Cabestre FA, et al. Semin Cancer Biol. 1999 Feb;9(1):27-36. doi: 10.1006/scbi.1998.0104. Semin Cancer Biol. 1999. PMID: 10092548 Review.